Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 177

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Multifunctional roles of enolase in Alzheimer’s disease brain: beyond altered glucose metabolism

Open access
Butterfield, D. Allan, Lange, Miranda L. Bader · 2009 · Journal of Neurochemistry

Abstract

Enolase enzymes are abundantly expressed, cytosolic carbon‐oxygen lyases known for their role in glucose metabolism. Recently, enolase has been shown to possess a variety of different regulatory functions, beyond glycolysis and gluconeogenesis, associated with hypoxia, ischemia, and Alzheimer’s disease (AD). AD is an age‐associated neurodegenerative disorder characterized pathologically by elevated oxidative stress and subsequent damage to proteins, lipids, and nucleic acids, appearance of neurofibrillary tangles and senile plaques, and loss of synapse and neuronal cells. It is unclear if development of a hypometabolic environment is a consequence of or contributes to AD pathology, as there is not only a significant decline in brain glucose levels in AD, but also there is an increase in proteomics identified oxidatively modified glycolytic enzymes that are rendered inactive, including enolase. Previously, our laboratory identified α‐enolase as one the most frequently up‐regulated and oxidatively modified proteins in amnestic mild cognitive impairment (MCI), early‐onset AD, and AD. However, the glycolytic conversion of 2‐phosphoglycerate to phosphoenolpyruvate catalyzed by enolase does not directly produce ATP or NADH; therefore it is surprising that, among all glycolytic enzymes, α‐enolase was one of only two glycolytic enzymes consistently up‐regulated from MCI to AD. These findings suggest enolase is involved with more than glucose metabolism in AD brain, but may possess other functions, normally necessary to preserve brain function. This review examines potential altered function(s) of brain enolase in MCI, early‐onset AD, and AD, alterations that may contribute to the biochemical, pathological, clinical characteristics, and progression of this dementing disorder.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1471-4159.2009.06397.x

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Cited by

See all 177

Metadata

Authors
Butterfield, D. A., & Lange, M. L. B.
Venue
Journal of Neurochemistry
Publisher
Wiley
Published
2009-10-16
Volume
111
Issue
4
Pages
915-933
ISSN
  • 0022-3042 (ISSN-L)
  • 1471-4159
OpenAlex
W1995859195
Cited by
177
References
15
FWCI
8.66
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Multifunctional roles of enolase in Alzheimer’s disease brain: beyond altered glucose metabolism. https://app.cochat.ai/papers/10.1111/j.1471-4159.2009.06397.x
The paper
Butterfield, D. A., & Lange, M. L. B. (2009). Multifunctional roles of enolase in Alzheimer’s disease brain: beyond altered glucose metabolism. Journal of Neurochemistry. https://doi.org/10.1111/j.1471-4159.2009.06397.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.